Cargando…
Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis
Type II focal cortical dysplasia (FCD) is a neuropathological entity characterised by cortical dyslamination with the presence of dysmorphic neurons only (FCDIIA) or the presence of both dysmorphic neurons and balloon cells (FCDIIB). The year 2021 marks the 50th anniversary of the recognition of FCD...
Autores principales: | Lee, Wei Shern, Baldassari, Sara, Stephenson, Sarah E. M., Lockhart, Paul J., Baulac, Stéphanie, Leventer, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835853/ https://www.ncbi.nlm.nih.gov/pubmed/35163267 http://dx.doi.org/10.3390/ijms23031344 |
Ejemplares similares
-
Gradient of brain mosaic RHEB variants causes a continuum of cortical dysplasia
por: Lee, Wei Shern, et al.
Publicado: (2021) -
Basal ganglia dysplasia and mTORopathy: A potential cause of postoperative seizures in focal cortical dysplasia
por: Lee, Wei Shern, et al.
Publicado: (2022) -
Second‐hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA
por: Lee, Wei Shern, et al.
Publicado: (2019) -
mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016) -
Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
por: Zimmer, Till S., et al.
Publicado: (2020)